Company Filing History:
Years Active: 1999
Title: **Innovative Contributions of Dominik Scherer in Chemical Research**
Introduction
Dominik Scherer is a notable inventor based in Horw, Switzerland, recognized for his significant contributions to the field of chemical research. With one patent to his name, Scherer has showcased his expertise in the development of aminomethyl-phenylimidazoles, a class of compounds with promising applications in neuroscience.
Latest Patents
Scherer's patent, titled "Preparation of Aminomethyl-Phenylimidazoles," involves the synthesis of these compounds through the reaction of an ester of a hydroxymethyl-phenylimidazole with an amine. Notably, the acetate ester is highlighted as a particularly preferred ester in his process. The resulting aminomethyl-phenylimidazoles demonstrate valuable properties as highly selective partial agonists or antagonists at specific brain dopamine receptor subtypes. Among the preferred compounds produced is 5-fluoro-2-(4-(2-phenyl-1H-imidazol-5-yl)methyl-1-piperazinyl)pyrimidine. Additionally, the esters of the hydroxymethyl-phenylimidazoles serve as useful intermediates in this innovative endeavor.
Career Highlights
Dominik Scherer is associated with Schering Corporation, where he applies his specialized knowledge to advance pharmaceutical research and development. His contributions have paved the way for innovative solutions in drug design and synthesis, focusing on compounds that target various neurological pathways. Scherer’s expertise and dedication to his field have earned him recognition among his peers.
Collaborations
Throughout his career, Scherer has collaborated with esteemed coworkers, including Dinesh Gala and Ingrid Mergelsberg. This teamwork has fostered an environment of creativity and innovation, allowing for the exploration of new ideas and methods in chemical research.
Conclusion
In summary, Dominik Scherer has made significant strides in the invention of aminomethyl-phenylimidazoles, reflecting his commitment to advancing pharmaceutical science. His work at Schering Corporation, along with his collaborative efforts, highlights the importance of teamwork in fostering innovation. Scherer's contributions continue to hold promise for the development of new therapeutic agents that may benefit various medical conditions, particularly in the field of neuroscience.